• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Utility of Two-Dimensional Difference Gel Electrophoresis in Diagnosis of Multiple Sclerosis.二维差异凝胶电泳在多发性硬化症诊断中的应用
Diagnostics (Basel). 2018 Jul 5;8(3):44. doi: 10.3390/diagnostics8030044.
2
[Establishment of two-dimensional differential gel electrophoresis using cerebrospinal fluid from neurocysticercosis patients].[利用神经囊尾蚴病患者脑脊液建立二维差异凝胶电泳法]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008 Jun 30;26(3):174-8.
3
Vitrification at the pre-antral stage transiently alters inner mitochondrial membrane potential but proteome of in vitro grown and matured mouse oocytes appears unaffected.在窦前阶段进行玻璃化处理会短暂改变线粒体膜电位,但体外培养和成熟的小鼠卵母细胞的蛋白质组似乎不受影响。
Hum Reprod. 2012 Apr;27(4):1096-111. doi: 10.1093/humrep/der453. Epub 2012 Jan 18.
4
The development of the DIGE system: 2D fluorescence difference gel analysis technology.DIGE系统的发展:二维荧光差异凝胶分析技术。
Anal Bioanal Chem. 2005 Jun;382(3):669-78. doi: 10.1007/s00216-005-3126-3. Epub 2005 May 18.
5
Evaluation of two-dimensional difference gel electrophoresis for protein profiling. Soluble proteins of the marine bacterium Pirellula sp. strain 1.二维差异凝胶电泳用于蛋白质谱分析的评估。海生细菌皮氏藻属菌株1的可溶性蛋白质。
J Mol Microbiol Biotechnol. 2003;5(4):240-51. doi: 10.1159/000071076.
6
Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE).癌症生物标志物的开发和二维差异凝胶电泳(2D-DIGE)。
Biochim Biophys Acta Proteins Proteom. 2019 Jan;1867(1):2-8. doi: 10.1016/j.bbapap.2018.07.002. Epub 2018 Jul 7.
7
Two-Dimensional Gel Electrophoresis and 2D-DIGE.二维凝胶电泳和二维差异凝胶电泳
Methods Mol Biol. 2018;1664:3-14. doi: 10.1007/978-1-4939-7268-5_1.
8
Two-Dimensional Difference Gel Electrophoresis.二维差异凝胶电泳
Methods Mol Biol. 2019;1855:229-247. doi: 10.1007/978-1-4939-8793-1_20.
9
2D-DIGE in Proteomics.蛋白质组学中的二维差异凝胶电泳
Methods Mol Biol. 2017;1654:245-254. doi: 10.1007/978-1-4939-7231-9_17.
10
Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.用于阿尔茨海默病早期诊断潜在生物标志物的血浆蛋白质谱分析。
Neurol Res. 2017 Mar;39(3):231-238. doi: 10.1080/01616412.2017.1281195. Epub 2017 Jan 20.

引用本文的文献

1
Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.基因组学、蛋白质组学和系统生物学方法在多发性硬化症生物标志物发现中的应用。
Cell Immunol. 2020 Dec;358:104219. doi: 10.1016/j.cellimm.2020.104219. Epub 2020 Sep 20.

本文引用的文献

1
Inflammasome Proteins As Biomarkers of Multiple Sclerosis.炎性小体蛋白作为多发性硬化症的生物标志物
Front Neurol. 2018 Mar 19;9:135. doi: 10.3389/fneur.2018.00135. eCollection 2018.
2
The use of cerebrospinal fluid in biomarker studies.脑脊液在生物标志物研究中的应用。
Handb Clin Neurol. 2017;146:3-20. doi: 10.1016/B978-0-12-804279-3.00001-0.
3
The cerebrospinal fluid in multiple sclerosis: far beyond the bands.多发性硬化症中的脑脊液:远不止条带现象
Einstein (Sao Paulo). 2017 Jan-Mar;15(1):100-104. doi: 10.1590/S1679-45082017RW3706.
4
Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis.
Br J Biomed Sci. 2016 Jul;73(3):143-146. doi: 10.1080/09674845.2016.1186310. Epub 2016 Jun 2.
5
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.多发性硬化症和视神经脊髓炎患者脑脊液的蛋白质组学分析。
Mol Med Rep. 2012 Nov;6(5):1081-6. doi: 10.3892/mmr.2012.1025. Epub 2012 Aug 8.
6
Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients.活性多发性硬化症患者脑脊液中补体蛋白的差异表达。
J Cell Biochem. 2011 Jul;112(7):1930-7. doi: 10.1002/jcb.23113.
7
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.多发性硬化症的诊断标准:2010 年麦克唐纳标准修订版。
Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.
8
Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.多发性硬化症患者脑脊液的定量蛋白质组学分析。
J Cell Mol Med. 2009 Aug;13(8A):1586-603. doi: 10.1111/j.1582-4934.2009.00850.x. Epub 2009 Jul 7.
9
CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.临床孤立综合征(CIS)中的脑脊液蛋白质组分析:转化为明确多发性硬化症的候选标志物
Neurosci Lett. 2009 Mar 13;452(2):214-7. doi: 10.1016/j.neulet.2009.01.057. Epub 2009 Jan 29.
10
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis.采用二维电泳技术对多发性硬化症患者脑脊液蛋白质组进行分析。
Eur J Neurol. 2008 Sep;15(9):998-1001. doi: 10.1111/j.1468-1331.2008.02239.x. Epub 2008 Jul 15.

二维差异凝胶电泳在多发性硬化症诊断中的应用

Utility of Two-Dimensional Difference Gel Electrophoresis in Diagnosis of Multiple Sclerosis.

作者信息

Auer Michael, Hegen Harald, Rudzki Dagmar, Golderer Georg, Deisenhammer Florian

机构信息

Department of Neurology, Medical University of Innsbruck, Innrain 66, 6020 Innsbruck, Austria.

Division of Biological Chemistry, Medical University of Innsbruck, Innrain 80-83, 6020 Innsbruck, Austria.

出版信息

Diagnostics (Basel). 2018 Jul 5;8(3):44. doi: 10.3390/diagnostics8030044.

DOI:10.3390/diagnostics8030044
PMID:29976874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6164878/
Abstract

Two-dimensional difference gel electrophoresis (2D-DIGE) has been used for identification of possible biomarkers in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. However, in different studies inconsistent results have been obtained. We wanted to analyze the diagnostic value of 2D-DIGE in early MS patients by comparing protein patterns between single and pooled samples of MS patients and controls. CSF samples of 20 MS patients and 10 control subjects were processed with 2D-DIGE. The so obtained protein patterns were analyzed with DeCyder 6.5 software, whereby we described variation of patterns presented in one gel as well as between different gels. Even when running single samples of patients of the same group in one gel, variation of protein patterns was high. The number of identified spots with different protein level varied between 4 and 30, depending on which sample batches were compared. We did not find a consistent pattern throughout all possible batch combinations. The inter-individual variation of protein expression as well as the susceptibility of 2D-DIGE for methodological variations makes use of 2D-DIGE as a diagnostic tool for MS and for detection of possible candidate biomarkers difficult, since detected proteins vary depending on which samples are compared.

摘要

二维差异凝胶电泳(2D-DIGE)已被用于鉴定多发性硬化症(MS)患者脑脊液(CSF)中可能的生物标志物。然而,在不同的研究中得到了不一致的结果。我们希望通过比较MS患者和对照的单个样本与混合样本之间的蛋白质模式,分析2D-DIGE在早期MS患者中的诊断价值。对20例MS患者和10例对照受试者的脑脊液样本进行2D-DIGE处理。用DeCyder 6.5软件分析所得的蛋白质模式,从而描述了在一块凝胶中以及不同凝胶之间呈现的模式变化。即使在一块凝胶中运行同一组患者的单个样本时,蛋白质模式的变化也很大。根据所比较的样本批次不同,鉴定出的具有不同蛋白质水平的斑点数量在4到30之间变化。在所有可能的批次组合中,我们都没有发现一致的模式。蛋白质表达的个体间差异以及2D-DIGE对方法学变化的敏感性使得将2D-DIGE用作MS的诊断工具以及检测可能的候选生物标志物变得困难,因为检测到的蛋白质会因所比较的样本不同而有所变化。